Top Markets
Coin of the day
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Hisse Senetlerindeki Sıralama #99999
Acticor Biotech SAS operates as a clinical stage biotechnology company that... Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Hisse Fiyatı
$0.28545656
Piyasa Değeri
$4.50M
Değişim (1 gün)
5.97%
Değişim (1 yıl)
0.00%
Ülke
FR
Ticaret Acticor Biotech SAS (ALACT)

Kategori

Acticor Biotech SAS (ALACT) için temettü verimi geçmişi
Acticor Biotech SAS (hisse sembolü: ALACT) temettü verimi (TTM) 2022-12-31 itibariyle: 0.00%
Son 5 yılın ortalama temettü verimi: 0.00%
Acticor Biotech SAS (ALACT) için 2010 - 2026 arası temettü verimi geçmişi
Her yılın sonunda temettü verimi (TTM)
Yıl Temettü Verimi Değiştir
2026 (TTM) 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
2011 0.00% 0.00%
2010 0.00% 0.00%
Benzer şirketler veya rakiplerin temettü verimi (TTM)